Proposed Singapore Paincare buyout ends after scheme conditions lapse
Financing confirmation were withdrawn after the expiry of UOB facilities.
The proposed acquisition of Singapore Paincare by Advance Bridge Healthcare ended after scheme conditions were not met by the 27 November 2025 cut-off date, according to a joint statement by both companies.
Singapore Paincare said the scheme required approval from eligible shareholders and other conditions that were not satisfied by the cut-off date, noting that several conditions under the implementation agreement could not be waived by either party.
Advance Bridge Healthcare stated that its financing facilities with UOB expired on 27 November 2025, causing the financial resources confirmation for the scheme to lapse. The offeror added that it lacked the assets, funds or collateral needed to obtain a fresh confirmation or secure alternative financing to extend the cut-off date.
Both companies said shareholders should review the announcement in full and obtain professional advice where necessary.